Skip to main content
Livermore
Livermore
ZHEN

Renaissance Technologies LLC

SEC CIK
0001037389
Latest filing
Aug 13, 2026

ACAD holding history

Acadia Pharmaceuticals Inc in every 13F filed by Renaissance Technologies LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ACAD overviewAll 13F holders of ACADFull Q2 2026 holdings

Shares (Q2 2026)
1,282,596
Value
$32.4M
% of portfolio
<0.1%
Quarters held
17
Since Q1 2021
Holdings of ACAD by Renaissance Technologies LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20261,282,596$32.4M<0.1%−441,600−25.6%ReducedHolders
Q1 20261,724,196$38.4M0.1%+191,600+12.5%AddedHolders
Q4 20251,532,596$40.9M0.1%+83,063+5.7%AddedHolders
Q3 20251,449,533$30.9M<0.1%−98,199−6.3%ReducedHolders
Q2 20251,547,732$33.4M<0.1%+70,699+4.8%AddedHolders
Q1 20251,477,033$24.5M<0.1%+250,500+20.4%AddedHolders
Q4 20241,226,533$22.5M<0.1%+823,333+204.2%AddedHolders
Q3 2024403,200$6.20M<0.1%−72,800−15.3%ReducedHolders
Q2 2024476,000$7.74M<0.1%−97,800−17.0%ReducedHolders
Q1 2024573,800$10.6M<0.1%+389,800+211.8%AddedHolders
Q4 2023184,000$5.76M<0.1%+184,000NewHolders
Q3 20230$00.0%−130,800−100.0%Sold outHolders
Q2 2023130,800$3.13M<0.1%+13,000+11.0%AddedHolders
Q1 2023117,800$2.22M<0.1%−197,900−62.7%ReducedHolders
Q4 2022315,700$5.03M<0.1%+278,000+737.4%AddedHolders
Q3 202237,700$617.0K<0.1%+37,700NewHolders
Q2 20220$00.0%−14,500−100.0%Sold outHolders
Q1 202214,500$351.0K<0.1%+14,500NewHolders
Q2 20210$00.0%−581,000−100.0%Sold outHolders
Q1 2021581,000$15.0M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.